Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 8, 2010, Pages 1390-1395

  Bos Veneman, Netty G P ^a   Bijzet, Johan ^a   Limburg, Pieter C ^a   Minderaa, Ruud B ^a   Kallenberg, Cees G ^a   Hoekstra, Pieter J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cytokines; Immune system; Obsessive compulsive symptoms; Soluble adhesion molecules; Tic disorders

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ARTICLE; CHILD; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; PROTEIN BLOOD LEVEL; TIC;

ADOLESCENT; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CHILD; CYTOKINES; FEMALE; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; SOLUBILITY; TIC DISORDERS;

EID: 78649513069     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.06.028     Document Type: Article

References (31)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR) 2000, American Psychiatry Association, Washington, DC.
2. Blann A.D., Daly R.J., Amiral J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996, 92:498-500.
3. Cardona F., Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 2001, 138:71-75.
4. Constans J., Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 2006, 368:33-47.
5. Dale R.C., Candler P.M., Church A.J., Wait R., Pocock J.M., Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol 2006, 172:187-197.
6. Dunn A.J. Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res 2006, 6:52-68.
7. Freeman R.D. Tic Disorders and ADHD - answers from a world-wide clinical data set on Tourette Syndrome. Eur Child Adolesc Psychiatry 2007, 16(I):15-23.
8. Gabbay V., Coffey B.J., Guttman L.E., Gottlieb L., Katz Y., Babb J.S., et al. A cytokine study in children and adolescents with Tourette's disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:967-971.
9. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989, 46:1006-1011.
10. Kansy J.W., Katsovich L., McIver K.S., Pick J., Zabriskie J.B., Lombroso P.J., et al. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol 2006, 181:165-176.
11. Kawikova I., Leckman J.F., Kronig H., Katsovich L., Bessen D.E., Ghebremichael M., et al. Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with tourette syndrome: a preliminary study. Biol Psychiatry 2007, 61:273-278.
12. King I.L., Segal B.M. Cutting edge: IL-12 induces CD4+. J Immunol 2005, 175:641-645.
13. Kirvan C.A., Swedo S.E., Snider L.A., Cunningham M.W. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 2006, 179:173-179.
14. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz K.L., Stevenson J., et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989, 28:566-573.
15. Leckman J.F., Katsovich L., Kawikova I., Lin H., Zhang H., Kronig H., et al. Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome. Biol Psychiatry 2005, 57:667-673.
16. Lit L., Gilbert D.L., Walker W., Sharp F.R. A subgroup of Tourette's patients overexpress specific natural killer cell genes in blood: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2007, 144:958-963.
17. Ma A., Koka R., Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 2006, 24:657-679.
18. Malek T.R. The biology of interleukin-2. Annu Rev Immunol 2008, 26:453-479.
19. Markiewicz M.A., Wise E.L., Buchwald Z.S., Cheney E.E., Hansen T.H., Suri A., et al. IL-12 enhances CTL synapse formation and induces self-reactivity. J Immunol 2009, 182:1351-1361.
20. Martino D., Church A.J., Defazio G., Dale R.C., Quinn N.P., Robertson M.M., et al. Soluble adhesion molecules in Gilles de la Tourette's syndrome. J Neurol Sci 2005, 234:79-85.
21. Martino D., Dale R.C., Gilbert D.L., Giovannoni G., Leckman J.F. Immunopathogenic mechanisms in tourette syndrome: A critical review. Mov Disord 2009, 24:1267-1279.
22. Morshed S.A., Parveen S., Leckman J.F., Mercadante M.T. Bittencourt Kiss MH, Miguel EC, et al. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol Psychiatry 2001, 50:566-577.
23. O'Rourke J.A., Scharf J.M., Yu D., Pauls D.L. The genetics of Tourette syndrome: a review. J Psychosom Res 2009, 67:533-545.
24. Rizzo R., Gulisano M., Pavone P., Fogliani F., Robertson M.M. Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. J Child Neurol 2006, 21:747-753.
25. Singer H.S., Giuliano J.D., Hansen B.H., Hallett J.J., Laurino J.P., Benson M., et al. Antibodies against human putamen in children with Tourette syndrome. Neurology 1998, 50:1618-1624.
26. Singer H.S., Hong J.J., Yoon D.Y., Williams P.N. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005, 65:1701-1707.
27. Singer H.S., Gause C., Morris C., Lopez P. Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics 2008, 121:1198-1205.
28. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998, 155:264-271.
29. Tang Y., Gilbert D.L., Glauser T.A., Hershey A.D., Sharp F.R. Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch Neurol 2005, 62:210-215.
30. Trinchieri G., Pflanz S., Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003, 19:641-644.
31. Yeh C.B., Wu C.H., Tsung H.C., Chen C.W., Shyu J.F., Leckman J.F. Antineural antibody in patients with Tourette's syndrome and their family members. J Biomed Sci 2006, 13:101-112.